4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-22-062438
CEO & Chief Scientific Officer sold 118,445 shares at an average $35.75 ($4,234,897)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zhang Jack Y. CEO & Chief Scientific Officer | 2022-05-16 | Sale | −54,274 | $35.58 | $1,931,188 | 2,287,740 | D |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2022-05-16 | Sale | −13,795 | $36.41 | $502,269 | 2,273,945 | D |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2022-05-17 | Sale | −47,539 | $35.74 | $1,698,906 | 2,226,406 | D |
| Zhang Jack Y. CEO & Chief Scientific Officer | 2022-05-17 | Sale | −2,837 | $36.14 | $102,534 | 2,223,569 | D |
| Open-market sales · 118,445 sh · avg $35.75 · $4,234,897 | |||||||
Loading xslF345X03/tm2215971-1_4seq1.xml…